USE OF FENOLDOPAM FOR THE TREATMENT OF HEMOLYTIC UREMIC SYNDROME

摘要

The present invention relates to the use of fenoldopam, its salts and/or derivatives for the treatment of hemolytic uremic syndrome (HUS), preferably in the form due to infection from Shiga-like toxin-producing Escherichia coli and in the atypical form.